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Introduction
Cytokinesis in animal and fungal cells is performed by the con-
certed action of a contractile actomyosin ring (AMR) and tar-
geted membrane deposition coupled with ECM remodeling at 
the division site (Balasubramanian et al., 2004; Strickland and 
Burgess, 2004). The AMR, which consists of myosin II and actin 
filaments, is thought to be the engine that drives the ingression 
of the plasma membrane at the division site during cytokinesis. 
However, important questions regarding the assembly and   
function of the AMR remain unanswered. For example, how is 
myosin II targeted to the division site? How does myosin direct 
actin ring assembly? How does the AMR coordinate with mem-
brane trafficking during cytokinesis?
The budding yeast Saccharomyces cerevisiae provides an 
excellent system for structure–function analysis of myosin II 
and for determining its role in cytokinesis, as deletion of MYO1, 
the sole myosin II in budding yeast, does not cause cell lethality 
in most strain backgrounds but produces serious defects in   
cytokinesis and cell separation (Bi et al., 1998; Schmidt et al., 
2002), permitting the in vivo analysis of a variety of myo1 mu-
tations. However, the structure of Myo1 is not known. In this 
study, we show by rotary-shadowing electron microscopy (EM) 
that Myo1 forms a dimer with a kink in its tail, similar to myo-
sin IIs in other eukaryotic cells.
To understand the function of a myosin II in cytokinesis, 
it is important to understand how it is targeted to the division 
site. Studies in multiple systems indicate that the targeting sig-
nals for cleavage-furrow localization reside in the tails of myo-
sin IIs (Sabry et al., 1997; Motegi et al., 2004; Lord et al., 2005; 
Lister et al., 2006; Beach and Egelhoff, 2009; Ronen and Ravid, 
2009). In addition, some proteins, such as Mid1, an anillin- 
related protein in fission yeast (Motegi et al., 2004; Wu et al., 
2006; Huang et al., 2008), and the septins, a family of GTP-
binding, filament-forming proteins (Longtine and Bi, 2003; Joo 
et al., 2005) in budding yeast (Bi et al., 1998; Lippincott and Li, 
1998) and mammalian cells (Joo et al., 2007), have been impli-
cated in myosin localization during cytokinesis. However, clear 
mechanisms that account for the entire myosin localization at 
the division site have not been elucidated in any organism.
In budding yeast, septins play important roles in Myo1 local-
ization (Bi et al., 1998; Lippincott and Li, 1998). However, how 
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To determine whether the Myo1 tail is sufficient for   
dimerization in vitro, Myo1 tail lacking the TD2 region was 
fused to maltose-binding protein (MBP), a known globular pro-
tein. MBP-Myo1-tail-TD2 was purified from Escherichia coli  
(Fig. 1 B) and its structure was visualized by rotary-shadowing 
EM. Again, MBP-Myo1-tail-TD2 molecules formed a “two-
headed” structure with a kinked tail (Fig. 1 B).
Together, these data demonstrate that Myo1 is a two-headed 
myosin II, resembling “conventional” myosins in other eukary-
otes. In addition, Myo1 has a clear kink in its tail, similar to 
myosin IIs from Dictyostelium, Acanthamoeba, smooth muscle, 
and nonmuscle cells (Trybus, 1991).
Myo1 tail contains two temporally distinct 
targeting domains
To identify potential targeting domains in Myo1, we constructed 
functional N- and C-terminally GFP-tagged MYO1 alleles and 
used them to make internal or terminal deletions of MYO1, 
leading to the identification of two distinct targeting domains, 
mTD1  (minimal  targeting  domain  1)  and  TD2  (targeting   
domain 2), in Myo1 tail (Fig. 1 C). Myo1 head or any other re-
gion of Myo1 tail did not localize to the division site in myo1 
cells, suggesting that mTD1 and TD2 are the only targeting   
domains of Myo1. A third region, the putative “assembly do-
main” (AD) allowed localization only in the presence of en-
dogenous Myo1 (Fig. 1 C). Strikingly, mTD1 localized to the 
division site in small- to large-budded cells, whereas TD2 localized 
to the division site only in large-budded cells (Fig. 1 D). Live-
cell imaging further demonstrates that mTD1 and TD2 mediate 
Myo1 localization before and during cytokinesis, respectively 
(see Fig. 4 A). Thus, Myo1 tail contains two temporally distinct 
targeting domains.
Myo1 targeting before cytokinesis depends 
on the septin-binding protein Bni5
Myo1 localization to the bud neck depends on the septins (Bi   
et al., 1998; Lippincott and Li, 1998). In addition, Myo1 tail 
carried on a high-copy plasmid suppressed the growth defect   
of various temperature-sensitive septin mutants (unpublished 
data), suggesting a close functional association of Myo1 with 
the septins. However, in vitro protein-binding assays using   
recombinant Myo1 targeting domains (MBP, MBP-TD1, MBP-
mTD1, and MBP-TD2) and septin complexes (Cdc3, Cdc10, 
Cdc11, and HisX6-Cdc12) failed to detect a convincing inter-
action between Myo1-TDs and the septins, which raises the   
possibility that a “linker protein” may be involved in Myo1–
septin interaction.
Bni5 localizes to the bud neck in a septin-dependent man-
ner from bud emergence in late G1 to spindle disassembly in 
telophase, which coincides with the onset of cytokinesis (Lee   
et al., 2002). In addition, both Bni5 and Myo1 appear to func-
tion in the same genetic pathway (Lee et al., 2002). These ob-
servations raise the possibility that Bni5 may link Myo1 to the 
septins before cytokinesis. To test this possibility, GFP-tagged 
Myo1, mTD1, and TD2 were visualized in wild-type and bni5 
cells. Strikingly, the full-length Myo1 localized to the division 
site only in large-budded bni5 cells, whereas the localization 
the septin hourglass recruits and maintains Myo1 at the divi-
sion site before cytokinesis and how Myo1 is anchored to the 
neck cortex flanked by two septin rings, which result from septin-
hourglass splitting at the onset of mitotic exit (Lippincott et al., 
2001),  during  cytokinesis  remain  unanswered.  In  this  study,   
we show that Myo1 is recruited to the division site via a biphasic 
mechanism involving distinct targeting signals in its tail and 
distinct molecular pathways.
AMR contraction and membrane trafficking are hallmarks 
of animal and fungal cytokinesis (Balasubramanian et al., 2004; 
Strickland and Burgess, 2004). The AMR is thought to generate 
force that powers plasma membrane ingression, whereas tar-
geted membrane deposition is thought to increase cell surface 
area and also to deliver cargo enzymes for ECM remodeling at 
the division site, which results in the formation of chitinous pri-
mary septum (PS) in budding yeast. These processes must co-
ordinate in time and space to achieve robust cytokinesis. However, 
the functional and mechanistic relationships between these pro-
cesses remain poorly understood. In this study, we present evi-
dence to suggest that the AMR functions as a structural unit to 
“guide” membrane trafficking and ECM remodeling at the divi-
sion site. This guidance role can be largely fulfilled without the 
motor domain of Myo1 in budding yeast, which can explain the 
striking observation made previously that the Myo1 tail is suffi-
cient to support cytokinesis (Lord et al., 2005). The generality 
of the guidance concept and the motor-independent role of the 
AMR in cytokinesis are discussed.
Results
Myo1 is a two-headed myosin with a kink in 
its tail
To determine the structure of full-length Myo1, we purified   
a C-terminally TAP-tagged Myo1 from yeast cells, expressed 
under its own promoter (Fig. 1 A). The TAP-tagged Myo1 con-
struct appears to function normally, as it did not cause any 
defects in cytokinesis and cell separation (unpublished data). 
We determined its structure by rotary-shadowing EM. Myo1 
formed dimers, each with two globular heads and a rod tail   
(Fig. 1 A). The average length of Myo1 tail (1073 aa, residues 
856–1928) was 126 ± 12 nm (n = 41). In addition, 56% of Myo1 
dimers displayed a clear “kink” or “hinge” in their tails, located 
at 46 ± 6 nm from the head–tail junction, which corresponds to 
the  predicted  helix-breaking  region  (236  aa,  residues  1176–
1411) in Myo1 tail (Fig. S1). To further validate the Myo1 
structure and confirm the kink position in its tail, a C-terminally 
TAP-tagged Myo1 with a deletion of the TD2 region (174 aa, 
residues 1224–1397; see next section) that contains all seven 
helix-breaking prolines in Myo1 tail (Fig. S1, red bar) was puri-
fied and its structure was determined. The tail length (118 ± 12 nm, 
n = 39) of Myo1-TD2 was reduced proportionally (Fig. 1 A), and 
the number of Myo1-TD2 dimers with kinked tails was also 
reduced to 31%, with the kink located at 41 ± 10 nm from the 
head–tail junction. The TD2 accounts for only a portion of the 
predicted helix-breaking region, which may explain why dele-
tion of the TD2 reduced, but did not eliminate, the propensity of 
the Myo1 tail to form a kink.1335 Myo1 tail-mediated targeting and furrow ingression • Fang et al.
These results demonstrate that Myo1 targeting before cytokinesis 
completely depends on Bni5.
To determine whether Myo1 and Bni5 interact directly, co-
immunoprecipitation and in vitro protein-binding assays were per-
formed. Myo1 tail fragments containing the mTD1 region (Tail, 
TD1, and mTD1; see Fig. 1 C), but not TD2 or the putative AD, 
interacted with Bni5 in yeast cell lysates (Fig. 2 C). Recombinant 
of mTD1 at the division site was completely eliminated (Fig. 2 A). 
In contrast, the localization of TD2 at the division site was un-
affected by bni5 (Fig. S2 A). Consistently, Bni5 colocalized 
with the full-length Myo1 at the bud neck until the onset of 
Myo1 ring constriction (Fig. 2 B, left; Video 1, left), whereas Bni5 
and the mTD1 colocalized at and co-disappeared from the bud 
neck precisely before cytokinesis (Fig. 2 B, right; Video 1, right). 
Figure 1.  Myo1 is a two-headed myosin and 
its tail contains two distinct targeting domains. 
(A) Myo1 heavy chain forms a dimer in yeast. 
Myo1-C-TAP and myo1-TD2-C-TAP were pu-
rified from strains XDY7 and XDY99, respec-
tively (left, silver staining), and observed by 
rotary-shadowing EM (right). (B) Recombinant 
myo1-Tail forms a dimer. MBP-myo1-Tail-TD2 
was purified from E. coli (left, Coomassie blue 
staining) and observed by rotary-shadowing 
EM (right). (C) Summary of localization data 
on Myo1 fragments. mTD1, minimal targeting 
domain 1; TD2, targeting domain 2; AD, as-
sembly  domain.  (D)  Localization  of  different 
Myo1 fragments during the cell cycle. Yeast 
strains (XDY41, YJL335A, YJL221A, YJL489A, 
YJL222A; see Table II) were used for observa-
tion. Bar, 1 µm.JCB • VOLUME 191 • NUMBER 7 • 2010   1336
Li, 1998). However, the TD2 still localized to the division site 
when cells were treated with latrunculin A (Fig. S2 B), a drug 
that disrupts all F-actin structures including the actin ring   
(Ayscough et al., 1997), suggesting that the TD2-mediated 
Myo1  targeting  may  involve  proteins  other  than  F-actin.   
A number of cytokinesis proteins such as Mlc1, Iqg1, Hof1, 
Cyk3, Inn1, and Chs2 localize to the division site before or 
around the time of TD2 localization, making them candidates 
for TD2-mediated Myo1 targeting. Strikingly, the TD2-GFP, 
carried on a plasmid, completely failed to localize in mlc1-11 
and iqg1 cells but still localized in other cytokinesis mutants 
MBP-TD1 and MBP-mTD1 interacted directly with recombinant 
GST-Bni5 (Fig. 2 D). In contrast, MBP or MBP-TD2 failed to   
interact with GST-Bni5. As previous results have demonstrated 
that Bni5 binds to the septin Cdc11 (Lee et al., 2002), these data 
establish Bni5 as a direct molecular linker between the septins and 
Myo1 (Septins → Bni5 → Myo1 [mTD1]) before cytokinesis.
Myo1 targeting during cytokinesis depends 
on ELC and IQGAP
The timing of TD2 localization is similar to that of actin ring 
assembly (Epp and Chant, 1997; Bi et al., 1998; Lippincott and 
Figure 2.  Myo1 targeting before cytokinesis 
depends on its interaction through mTD1 with 
Bni5.  (A)  Localization  of  Myo1  and  myo1-
mTD1  in  wild-type  and  bni5  cells.  Cells 
carrying  MYO1-GFP  or  myo1-mTD1-GFP  in 
wild-type  (BNI5)  (YXD41  and  YJL489A)  or 
bni5  (XDY254  and  XDY258)  backgrounds 
were grown in YPD at 23°C and observed by 
DIC and fluorescence microscopy. (B) Strains 
YEF6321  (MYO1-GFP  BNI5-RFP;  left)  and 
YEF6326  (myo1-mTD1-GFP  BNI5-RFP;  right) 
were grown in YPD at 23°C and then imaged 
by  3D  dual-color  time-lapse  microscopy  at 
23°C with a 2-min interval. Montage images 
of the GFP, RFP, and merged channels from 
the representative time-lapse data are shown 
here. Arrowhead indicates the start of Myo1 
ring  constriction.  (C)  myo1-mTD1  interacts 
with  Bni5  in  yeast.  GFP-tagged  Myo1  frag-
ments  were  immunoprecipitated  using  anti-
GFP antibody from cell lysates of yeast strains 
(XDY189,  XDY190,  XDY191,  XDY192,  and 
XDY194;  see  Table  II).  Myo1  fragments  (IP) 
and Bni5-3HA (Bound) in the precipitates were   
detected by Western blot analyses using anti-
bodies  against  GFP  and  HA,  respectively.   
(D)  myo1-mTD1  interacts  with  Bni5  in  vitro. 
Equal amounts of MBP, MBP-myo1-TD1, MBP-
myo1-mTD1,  and  MBP-myo1-TD2  bound  to 
amylose beads were mixed individually with 
the same amount of GST-Bni5. The pulled down 
MBP and MBP-myo1 fragments as well as GST-
Bni5  in  the  bound  and  input  fractions  were 
detected by Western blot analyses using anti-
bodies against MBP and GST, respectively.1337 Myo1 tail-mediated targeting and furrow ingression • Fang et al.
contains an APC recognition site (Ko et al., 2007; Tully et al., 
2009) and a CHD (calponin-homology domain; Shannon and 
Li, 1999), was dispensable for TD2 localization (Fig. 3 C). To 
date, we failed to detect a convincing interaction between dif-
ferent Iqg1 fragments and the TD2 by two-hybrid and in vitro 
protein-binding assays (unpublished data), which may reflect 
complex regulation of this interaction or an interaction that   
is bridged by other proteins in vivo. Nonetheless, our results, 
together with the previous observation that Mlc1 binds to   
the IQ motifs of Iqg1 and is required for the localization of 
(hof1,  cyk3,  hof1  cyk3,  inn1,  and  chs2;  all  these 
strains contain the endogenous MYO1; Fig. 3 A and unpub-
lished  data).  More  importantly,  the  GFP-tagged  full-length 
Myo1 disappeared from the bud neck in mlc1-11 and iqg1 
cells precisely at the time of septin-hourglass splitting (Fig. 3 B; 
Video 2), which coincides with the onset of mitotic exit or   
cytokinesis (Lippincott et al., 2001). Thus, the TD2-mediated 
Myo1 targeting depends on Mlc1 (the ELC [essential light 
chain] for Myo1) and Iqg1 (IQGAP; Shannon and Li, 2000; 
Luo  et  al.,  2004).  The  N-terminal  region  of  Iqg1,  which   
Figure 3.  Myo1 targeting during cytokinesis depends on Mlc1 and Iqg1. (A) myo1-TD2 localization depends on Mlc1 and Iqg1. Wild-type (WT) (XDY154), 
mlc1-11 (XDY173), and iqg1 (XDY218) cells carrying plasmid pRS316-MYO1-TD2-GFP were grown in SC-Ura medium at 23°C and then examined for 
myo1-TD2 localization. (B) Full-length Myo1 localization depends on Mlc1 and Iqg1. Strains YEF6179 (mlc1-11 MYO1-GFP CDC3-RFP; left) and YEF6325 
(iqg1 CDC3-RFP, pRS316-MYO1-C-GFP; right) were grown in liquid SC-Leu media at 23°C and then imaged by 3D dual-color time-lapse microscopy at 
23°C with a 1-min interval. Montage images of the GFP, RFP, and merged channels from the representative time-lapse data are shown here. Arrowheads 
indicate the splitting of septin hourglass into two cortical rings, which coincides with mitotic exit and the onset of cytokinesis. (C) myo1-TD2 localization in 
cells containing different iqg1 alleles. Plasmid pRS315 derivatives carrying the indicated iqg1 alleles (see Table III) were transformed into strain XDY218. 
Transformants were grown in SC-Ura-Leu medium at 23°C and then quantified for myo1-TD2 localization. APC, APC/C recognition site; CHD, calponin-
homology domain; IQ, IQ motifs; Ras-GAP, RasGAP-related domain; RasGAP-C, RasGAP C terminus–related domain.JCB • VOLUME 191 • NUMBER 7 • 2010   1338
very few cells containing myo1-TD2-GFP displayed complete 
and symmetric ring constriction (Fig. S3 B; Video 6, middle 
and right). These data indicate that the TD2 is sufficient for 
Myo1 targeting but not its function during cytokinesis.
In summary, we have established a biphasic targeting 
mechanism for Myo1 during the cell cycle. The early targeting 
mechanism  accounts  for  Myo1  localization  from  late  G1  to 
telophase, which reflects the localization pattern of Bni5 during 
the cell cycle (Lee et al., 2002; Fig. 2 B). In contrast, the late 
targeting mechanism accounts for Myo1 localization from ana-
phase to the completion of cytokinesis, which reflects the local-
ization pattern of Iqg1 during the cell cycle (Epp and Chant, 1997; 
Lippincott and Li, 1998). These two targeting events overlap 
from anaphase to telophase when Bni5 and Iqg1 coexist at the 
bud neck.
Myo1 tail is sufficient for directing 
actomyosin ring assembly and primary 
septum formation during cytokinesis
To  determine  the  functional  consequences  of  the  distinct   
targeting mechanisms for Myo1, we examined the effects of in-
activating each of the mechanisms on the execution of cytokinesis 
by examining cell cluster formation, which is indicative of a 
failure in cytokinesis and/or cell separation. As observed previ-
ously (Lord et al., 2005), myo1-Tail cells, possessing both target-
ing domains, displayed a mild defect in cytokinesis (Fig. 5 A). 
Similarly, bni5 cells, in which the early targeting of Myo1 is 
eliminated,  displayed  little  defect  in  cytokinesis,  suggesting 
that the late targeting of Myo1 is largely responsible for its role 
in cytokinesis. This conclusion is further supported by the ob-
servation that myo1-TD2 cells, containing only the 174-aa late 
targeting domain, were able to carry out cytokinesis much more 
efficiently than myo1 cells did. Surprisingly, myo1-TD2 
cells, in which the mutant myo1 protein disappears invariably 
by the onset of mitotic exit (Fig. 4 A), were also able to carry 
out cytokinesis more efficiently than myo1 cells did, although 
much poorly than myo1-tail cells. This result suggests that 
Myo1 localization before the onset of mitotic exit also contrib-
utes to cytokinesis, which is further corroborated by the striking 
observation that the bni5 myo1-TD2 cells, in which both tar-
geting mechanisms are inactivated, displayed a cytokinesis de-
fect similar to that of myo1 cells (Fig. 5 A). These data indicate 
that Myo1 tail is largely sufficient for cytokinesis, and both tar-
geting mechanisms contribute.
To  explore  the  underlying  mechanism  for  the  role  of 
Myo1 tail and its targeting domains in cytokinesis, we exam-
ined actin ring assembly in various myo1 mutants. As expected, 
98% of wild-type cells with segregated nuclei formed an actin 
ring, whereas myo1 cells at the similar stage of the cell cycle 
did not (Bi et al., 1998). Remarkably, 92% of the myo1-Tail 
cells assembled an actin ring (Fig. 5 B; Fig. S4 A; Video 7), sug-
gesting that Myo1 tail is sufficient for promoting actin ring as-
sembly and/or maintaining actin filaments independently of the 
head domain, which contains the only known actin-binding site 
among all myosin IIs. Both targeting domains contribute to   
actin ring assembly, as cells lacking either were compromised   
severely in both the frequency and the quality of actin ring   
Iqg1 to the division site (Shannon and Li, 2000), establish a 
pathway (ELC → IQGAP → Myo1 [TD2]) for Myo1 targeting 
during cytokinesis.
Distinct targeting mechanisms account  
for distinct Myo1 localization patterns  
and dynamics during the cell cycle
To determine how different targeting mechanisms affect Myo1 
localization patterns and dynamics during the cell cycle, we 
performed 3D time-lapse analyses on cells with intact targeting 
mechanisms or with one mechanism selectively inactivated.   
In these experiments, all mutant alleles of MYO1 were the sole 
source of Myo1 in the cell. Although the overall localization 
pattern of Myo1 tail, which contains both targeting signals, was 
similar to that of full-length Myo1 (Fig. 4 A), several differ-
ences were noted. Myo1 tail displayed a 21% decrease in the 
rate of ring “constriction” (Fig. 4 B; Lord et al., 2005; constric-
tion refers to a reduction in the size of Myo1 ring and does not 
imply the involvement of an actomyosin-based contractile 
force), and also a defect in ring disassembly (Fig. 4 A; Fig. S3 A; 
Video 3, compare right to left). Some myo1-Tail cells displayed 
asymmetric or partial ring constriction (Fig. S3 B). These data 
indicate that Myo1 head accounts for about one fifth of the con-
striction rate of the Myo1 ring during cytokinesis and also sug-
gest that Myo1 head contributes to Myo1 disassembly during 
and toward the end of cytokinesis.
To determine the precise timing and dynamics of Myo1 
localization conferred by the early targeting mechanism, we   
examined myo1-TD2-GFP cells where the region sufficient 
for late targeting of Myo1 is deleted. myo1-TD2-GFP local-
ized to the incipient bud site and the bud neck as full-length 
Myo1-GFP did, but its intensity began to fade 10–15 min   
before and disappeared completely from the division site with-
out any constriction around the time of septin-hourglass split-
ting (Fig. 4, A and B; Video 4), which marks the onset of mitotic 
exit (telophase–G1 transition; Lippincott et al., 2001). As ex-
pected, myo1-TD2-GFP failed to localize to the bud neck in 
bni5 cells throughout the cell cycle (Video 5). These data indi-
cate that the early targeting mechanism of Myo1 is responsible for 
its localization from late G1 to telophase, and this targeting 
event completely depends on Bni5.
To determine the precise timing and dynamics of Myo1 
localization conferred by the late targeting mechanism, we ex-
amined two complementary situations. In bni5 cells where the 
early targeting mechanism is eliminated (Fig. 2, A and B), full-
length Myo1 began to appear at the division site 15 min and 
reached  maximal  intensity  5  min  before  septin-hourglass 
splitting, and then Myo1 ring constricted with a decreased rate 
but  did  not  linger  around  the  division  site  after  cytokinesis   
(Fig. 4, A and B; Video 6, left). These data further demonstrate 
the role of Bni5 in the early targeting of Myo1, and suggest that 
the late targeting mechanism of Myo1 is responsible for its   
localization from anaphase to the completion of cytokinesis.
In a complementary experiment, myo1-TD2-GFP alone 
localized to the division site in a pattern that parallels that of 
Myo1 in bni5 cells during the cell cycle (Fig. 4 A). However, 
in contrast to Myo1 tail or full-length Myo1 in bni5 cells, 1339 Myo1 tail-mediated targeting and furrow ingression • Fang et al.
“F-actin cloud” (Fig. S4, A and B). In contrast, 72% of the bni5 
cells formed an actin ring (Fig. S4 A), suggesting a minor   
contribution of Bni5 to this process. These data indicate that 
assembly.  Only  33%  and  42%  of  the myo1-TD2  and  myo1-
TD2 cells formed abnormal actin structures at the division   
site, which ranged from a smooth actin ring to an amorphous 
Figure 4.  Distinct targeting mechanisms impart distinct Myo1 localization dynamics during the cell cycle. (A) Effects of bni5 and myo1 truncations on 
the dynamics of Myo1 localization during the cell cycle. Cells of strains XDY286 (MYO1-GFP; n = 33), XDY287 (MYO1-GFP bni5; n = 38), XDY288 
(myo1-Tail-GFP; n = 88), XDY289 (myo1-TD2-GFP; n = 42), and XDY290 (myo1-TD2-GFP; n = 31) were grown in YPD at 23°C and then imaged by 3D 
dual-color time-lapse microscopy at 23°C with a 1-min interval. Montage images from the representative time-lapse data are shown here. Top row in each 
image panel: Cdc3-RFP (red); middle row: Myo1*-GFP (asterisk indicates Myo1 or its fragment; green); bottom row: merged images of septin-RFP and 
Myo1*-GFP. The merged images were used to determine the symmetry of Myo1*-GFP ring during its localization and/or constriction. Arrowheads indicate 
septin-hourglass splitting. Images within each image panel were processed with the same magnification. (B) Constriction rates of Myo1 and its fragments 
in wild-type and/or bni5 cells. “a” indicates that only cells showing symmetric Myo1 constriction were used for the calculation.JCB • VOLUME 191 • NUMBER 7 • 2010   1340
Figure 5.  Motor-independent roles of Myo1 in promoting actin ring assembly and furrow ingression. (A) Cytokinesis defects in bni5 and different myo1 
mutants. Cells of strains listed below were grown in YPD at 23°C and scored for cytokinesis defects as follows: mild cytokinesis defect, cells with 3–4 cell 
bodies linked together; strong cytokinesis defect, cells with more than 4 cell bodies linked together. The number of cells scored for each strain was 500. 
The strains were XDY41 (MYO1-GFP), XDY254 (MYO1-GFP bni5), YJL335A (myo1-Tail-GFP), YJL222A (myo1-TD2-GFP), YJL488A (myo1-TD2-GFP), 
YEF6322 (myo1-TD2-GFP bni5), and YEF1804 (myo1). (B) Myo1 tail is sufficient for promoting actin ring assembly. Cells of the strains YEF6307 
(MYO1-GFP NUP57-GFP; top) and YEF6309 (myo1-Tail-GFP NUP57-GFP; bottom) were grown in SC-Ura media at 23°C, fixed, and stained for actin, and 
then imaged by spinning-disk confocal microscopy along the Z-axis with a 0.1-µm increment (71 and 46 Z-sections for wild-type and myo1-Tail cells, respec-
tively). For clear visualization of the actin ring, images of a single focal plane near the middle of the cell were presented (see Video 7 for 3D construction 
of the actin ring in a myo1-Tail cell). Myo1*-GFP indicates GFP-tagged Myo1 or its tail. (C) AMR constriction (marked by Myo1-RFP) is spatiotemporally 1341 Myo1 tail-mediated targeting and furrow ingression • Fang et al.
Both Myo1 and actin filaments are involved 
in guiding primary septum formation  
during cytokinesis
The functionality of Myo1 tail in cytokinesis appears to be cor-
related with its ability to direct actin ring assembly. This raises 
an interesting possibility that Myo1 tail may simply help actin 
filaments organize into a ring structure at the division site, and 
it is the actin filaments that actually direct trafficking and PS 
formation  by  capturing  and  distributing  post-Golgi  vesicles 
around the circumference of the division site. The vesicles are 
delivered to the division site from the Golgi by the myosin V 
Myo2 along actin cables (Pruyne et al., 1998; Moseley and 
Goode, 2006). Thus, the actin filaments in actin cables and actin 
ring, both of which are nucleated by formins (Vallen et al., 
2000; Evangelista et al., 2002; Sagot et al., 2002; Tolliday et al., 
2002), may function as a “relay team” to control membrane 
trafficking and ECM remodeling during cytokinesis. To test this 
hypothesis, we attempted to selectively eliminate actin ring as-
sembly while leaving actin cables intact. This was achieved by 
deleting the calponin-homology domain (CHD) in Iqg1. As shown 
previously (Shannon and Li, 1999), the CHD is required for   
actin ring assembly (Fig. 6 A). 73% of the IQG1 cells (n = 60) with 
segregated nuclei formed an actin ring, in contrast to only 9% of 
the iqg1-CHD cells (n = 43). In addition, Myo1-GFP ring 
showed no or little constriction before disassembling several 
minutes after mitotic exit in iqg1-CHD cells (n = 12), in con-
trast to the normal constriction and disassembly in IQG1 cells 
(n = 15; Fig. 6 B; Video 10, compare right to left). 100% of 
the IQG1 and iqg1-CHD cells with any septal materials at   
Myo1 tail is sufficient for actin ring assembly, and again, both 
targeting domains contribute.
How does the “headless” AMR assembled by Myo1 tail 
drive cytokinesis? In wild-type cells, AMR constriction (marked 
by Myo1-RFP) and membrane trafficking (marked by myosin V 
Myo2-GFP) or trafficking-dependent PS formation (marked by 
chitin synthase Chs2-GFP) are spatiotemporally coupled during 
cytokinesis (Fig. 5 C; Video 8). Both Myo2 and Chs2 arrive at 
the division site around septin-hourglass splitting (Fig. S4 C; 
Video 9), which coincides with the onset of AMR contraction. 
The AMR has been suggested to guide PS formation and/or cell 
surface growth in budding yeast (Vallen et al., 2000; Bi, 2001). 
We tested the possibility that the headless AMR may retain the 
“guiding role” even in the absence of its motor domain by ex-
amining PS formation in various myo1 mutants using transmis-
sion EM (Fig. 5 D; Table I). As expected, wild-type cells formed 
the PS with high efficiency (100% of the large-budded cells 
with any septal materials at the division site had a PS) and a 
sharp orientation (perpendicular to the mother–daughter axis), 
whereas myo1 cells formed asymmetric and/or grossly mis-
oriented PS with low efficiency (66%). Remarkably, myo1-tail 
cells formed PS with high efficiency (100%) and an orientation 
close to wild-type cells. Thus, the headless AMR is able to 
guide PS formation. When either targeting domain was deleted 
such as in myo1-TD2 and myo1-TD2 cells, the efficiency and 
the orientation of PS formation were severely compromised 
(Fig. 5 D; Table I). Together, these data demonstrate that Myo1 
tail is sufficient for directing AMR assembly and PS formation 
during cytokinesis.
coupled with membrane trafficking (marked by Myo2-GFP) and PS formation (marked by Chs2-GFP). Cells of strains YKT662 (MYO2-GFP) and YEF5762 
(CHS2-GFP) carrying pRS316-MYO1-mCherry were grown in YPD at 23°C and then imaged by time-lapse microscopy at 23°C with a 1-min interval. 
Representative montage images of the time-lapse data are shown here. Arrowheads indicate the start of Myo1 ring constriction. (D) Septum morphology 
in wild-type and different myo1 mutants. The indicated strains listed in A were processed to visualize septum formation by transmission EM (left) and the 
orientation of the PS in different strains was measured (diagram; see footnote of Table I for details) and plotted. CW, cell wall; PM, plasma membrane; 
SS, secondary septum.
 
Table I. PS formation in different myo1 mutants
a
PS morphological trait MYO1-GFP  
(XDY41)
myo1-Tail-GFP 
(YJL335A)
myo1-TD2-GFP 
(YJL222A)
myo1-TD2-GFP 
(YJL488A)
myo1  
(YEF1804)
No PS (= only SS) 0 0 6 12 23
1 PS
b 57 37 21 30 20
2 PSs 11 25 28 20 14
3 PSs 0 5 10 6 6
4 PSs 0 0 2 0 5
5 PSs 0 1 1 0 0
Total 68 68 68 68 68
PS index
c (%) 100 100 91 82 66
Neck-spanning index
d (%) 84 76 23 21 7
PS angles
e (mean ± SD) 8 ± 5 15 ± 11 36 ± 41 20 ± 24 49 ± 42
aOnly cells with any sign of septum formation, regardless of its types (PS, primary septum; SS, secondary septum), and with no visible division scars were scored.   
The latter is to minimize possible mis-scoring of structures from previously formed septa.
bAn electron-translucent stripe originated from the bud–neck region was defined as one PS.
cNumber of cells with any PS divided by number of cells with any septum (PS or SS).
dNumber of cells with a PS spanning the entire bud neck divided by number of cells with any PS.
eThe angle between two lines starting from the base of a given PS was measured: one line is perpendicular to the mother–bud axis and the other connects to a site 
along the PS that yields the biggest angle (it could be at the tip or in the middle of the PS). Only cells with one or two PSs that extended at least one quarter of the 
bud–neck width were used for measurement (see also Fig. 5 D).JCB • VOLUME 191 • NUMBER 7 • 2010   1342
Figure 6.  Actin ring plays a role in guiding PS formation. (A) Actin ring assembly in iqg1-CHD mutant. Cells of strains RNY2594 (iqg1 MYO1-GFP, 
pRS315-IQG1-GST) and RNY2595 (iqg1 MYO1-GFP, pRS315-IQG1[2-411]-GST) were grown in SC-Leu media at 23°C and then fixed and stained for 
actin and DNA. (B) Abnormal constriction of the Myo1-GFP ring in iqg1-CHD mutant. Cells of the strains RNY2596 (iqg1 MYO1-GFP CDC3-mCherry, 
pRS315-IQG1-GST) and RNY2597 (iqg1 MYO1-GFP CDC3-mCherry, pRS315-IQG1[2-411]-GST) were grown in SC-Leu media at 23°C and then   
imaged by time-lapse microscopy at 23°C with a 1-min interval. Arrowheads indicate septin-hourglass splitting. (C) PS formation in iqg1-CHD mutant. PS of 
the strains listed in A were visualized by transmission EM and the orientation of the PS was quantified as in Fig. 5 D.1343 Myo1 tail-mediated targeting and furrow ingression • Fang et al.
Lister  et  al.,  2006;  Beach  and  Egelhoff,  2009).  However,   
it has not been clear what interactions recruit and/or maintain 
myosins at the division site. We demonstrate here that Myo1 
undergoes biphasic targeting through distinct molecular path-
ways during the cell cycle. Such a mechanism may be generally 
applicable to the targeting of myosin II to the cleavage furrow   
in other organisms.
The first-phase targeting accounts for Myo1 localization 
at the bud neck before cytokinesis. At this stage of the cell cycle, 
Myo1 may facilitate the retrograde flow of actin cables nucle-
ated at the bud cortex in a motor-dependent manner as described 
previously (Huckaba et al., 2006; Fig. 7 A). Targeting at this 
stage requires the function of a molecular pathway (septins → 
Bni5 → Myo1). Basically, Bni5 interacts directly with the septin 
Cdc11 (Lee et al., 2002) and with the mTD1 of Myo1, thereby 
targeting Myo1 to the bud neck before cytokinesis. This may be 
conceptually similar to the initial targeting of the myosin II Myo2 
in fission yeast, which requires Mid1, an anillin-related protein 
that is important for the selection of division plane as well as for 
efficient AMR assembly (Motegi et al., 2004; Wu et al., 2006; 
Huang et al., 2008). In both cases, the initial targeting mecha-
nism acts before cytokinesis and requires some proteins that 
are not well conserved throughout evolution, such as Bni5 and 
Mid1. Thus, the initial targeting mechanism may have evolved 
to accommodate the unique life style of a particular organism.
The second-phase targeting accounts for Myo1 localiza-
tion at the bud neck during cytokinesis. This targeting requires 
the function of a distinct molecular pathway (Mlc1 → Iqg1 → 
Myo1). Mlc1 and Iqg1 are the sole ELC and IQGAP in budding 
yeast. Mlc1 interacts with Iqg1 and is required for Iqg1 local-
ization to the bud neck (Boyne et al., 2000; Shannon and Li, 
2000). We show here that Myo1 targeting during cytokinesis 
depends on Mlc1 and Iqg1 and this targeting is mediated through 
the TD2 of Myo1. Importantly, this targeting pathway is cou-
pled with AMR assembly during cytokinesis, as all three com-
ponents of the pathway are required for actin ring assembly 
(Epp and Chant, 1997; Bi et al., 1998; Shannon and Li, 2000). 
One possibility is that the rod-shaped Myo1 tail, after being re-
cruited to the division site by Iqg1, serves as a “template” for 
actin ring assembly. For example, Myo1 tail could assemble 
into a higher-order structure that enables Iqg1 and other ring 
components to distribute more evenly along the circumference 
of the division site. Alternatively, Myo1 tail may activate Iqg1 
to bind to actin filaments via its CHD (Shannon and Li, 1999), 
thereby promoting actin ring assembly.
In fission yeast, Myo2 can still localize to the cell cortex 
and promote AMR assembly in mid1 cells in which the early 
targeting mechanism is inactivated (Motegi et al., 2004; Wu   
et al., 2006; Huang et al., 2008), suggesting the existence of a 
Mid1-independent Myo2 targeting mechanism. This second 
mechanism likely involves Cdc4, the ELC in fission yeast, as 
Cdc4 is required for Myo2 localization at the division site whereas 
Myo2 is not required for Cdc4 localization (Naqvi et al., 1999). 
Currently, it is not known whether Rng2, the IQGAP in fission 
yeast, is required for the second-phase targeting by acting in a 
linear pathway between Cdc4 and Myo2, as Iqg1 does in bud-
ding yeast. Importantly, Rng2 is also required for actin ring   
the division site formed one or more PS, but the mutant cells 
were defective in the orientation of the PS (Fig. 6 C). These data 
suggest that the absence of actin filaments in the AMR causes a 
slight delay in the initiation of PS formation (as manifested by 
the lack of Myo1 ring constriction) and a defect in PS guidance. 
However, the iqg1-CHD cells showed much a milder defect in 
PS orientation than the myo1 cells did (compare to Fig. 5 D), 
suggesting that Myo1 plays a major role in PS guidance inde-
pendently of the actin ring. Together, these results indicate that 
both Myo1 and actin filaments in the AMR are involved in guid-
ing PS formation during cytokinesis.
Discussion
The kink region of Myo1 tail is required  
for its targeting to the division site  
during cytokinesis
In this study, we have shown that full-length Myo1 purified 
from yeast cells forms a two-headed structure, resembling “con-
ventional” myosins from animal cells. This finding is consistent 
with the conserved nature of this family of motor proteins, and 
refutes the speculation that Myo1 might be a single-headed   
myosin (Bezanilla and Pollard, 2000). It also differs from a pre-
vious observation showing that a Myo1 fragment (residues 
1044–1569) forms trimers and oligomers but not dimers (Lister 
et al., 2006). This discrepancy could simply reflect different in 
vitro biochemical behaviors exhibited by a full-length protein 
versus its fragments. Whether and how Myo1 is assembled into 
higher-order structures such as mini- and/or thick filaments and 
whether this assembly is required for cytokinesis will be investi-
gated in the future.
Myosin IIs from Dictyostelium, Acanthamoeba, smooth 
muscle, and nonmuscle cells all display a “kink” or “hinge” in 
their tails (Trybus, 1991), which may correspond to a region 
that is predicted to break the helical structure (Fig. S1). The 
kink is thought to mediate the formation of an auto-inhibitory 
loop by individual myosin molecules, which can be opened by 
regulatory light-chain or heavy-chain phosphorylation for myo-
sin activation and higher-order assembly (Trybus, 1991). Myo1 
clearly forms a kink in its tail that corresponds to the predicted 
helix-breaking region, including the TD2 (Fig. S1). The TD2, 
which was called the putative hinge in a previous study, was re-
ported to be essential for Myo1 contraction (Lister et al., 2006). 
The underlying assumption was that Myo1 lacking the TD2 
could still localize to the division site but fail to contract during 
cytokinesis. However, here we showed that the TD2 is actually 
required for Myo1 localization during cytokinesis, as opposed 
to being required for Myo1 contraction, per se. The difference 
is that no cell cycle marker for cytokinesis was used in the pre-
vious study. These results suggest that the kink region of a myo-
sin II may play important roles in its localization.
Biphasic targeting of Myo1 during the 
cell cycle: a general feature of myosin II 
targeting mechanisms?
The tail of a myosin II is responsible for its targeting to the divi-
sion site (Sabry et al., 1997; Motegi et al., 2004; Lord et al., 2005; JCB • VOLUME 191 • NUMBER 7 • 2010   1344
presumably by interacting with an unknown protein. It would 
be intriguing to determine whether ELC and IQGAP are involved 
in myosin II targeting during cytokinesis in Dictyostelium as 
well as in mammalian cells. Interestingly, the tail of the non-
muscle myosin II in mammalian cells is also able to enrich actin 
filaments at the division site (Beach and Egelhoff, 2009), sug-
gesting that myosin tail–mediated actin assembly at the division 
site is not restricted to budding yeast. Taken together, our study 
and the existing literature suggest that the second-phase target-
ing  mechanism  may  function  to  couple  myosin  localization 
with AMR assembly during cytokinesis in yeast and beyond.
Actomyosin ring guides membrane 
deposition and ECM remodeling  
during cytokinesis
How can a headless AMR assembled by Myo1 tail achieve cyto-
kinesis with reasonable efficiency? To answer this question, we must   
consider the forces acting at the division site during cytokinesis.
There are two main forces acting at the division site to 
power plasma membrane ingression during cytokinesis (Fig. 7 B). 
First, the contractile force generated by the sliding of myosin 
motor on actin filaments, which depends on the actin-binding 
and ATPase activities of the myosin head; this force is tradition-
ally thought to be the most important. Second, the force gener-
ated by new membrane deposition coupled with centripetal PS 
formation in yeast and ECM remodeling in animal cells. In bud-
ding yeast, PS formation is essential for plasma membrane in-
gression and thus cytokinesis (Bi, 2001; Schmidt et al., 2002; 
VerPlank and Li, 2005). In Caenorhabditis elegans and mice, 
the synthesis of the ECM component chondroitin proteoglycan 
is essential for embryonic cytokinesis (Mizuguchi et al., 2003; 
Izumikawa et al., 2010).
The two driving forces for membrane closure during   
cytokinesis  must  be  coordinated  in  time  and  space  to  achieve   
efficiency and spatial precision. Increasing evidence suggests 
that AMR assembly and/or contraction and membrane deposi-
tion appear to be interdependent in fungal and animal cells   
(Balasubramanian et al., 2004; Strickland and Burgess, 2004). 
In budding yeast, the AMR is thought to “guide” membrane de-
position and PS formation (Vallen et al., 2000; Bi, 2001), which 
requires a major contribution from Myo1 and a minor contribu-
tion from the actin ring (Figs. 5 and 6). How Myo1 fulfills its 
guidance role independently of the actin ring remains unknown. 
The actin ring may fulfill its guidance role as part of a “relay 
team” with the actin cables (Fig. 7 B). Once post-Golgi vesicles 
are transported by myosin V along actin cables to the division 
site (Pruyne et al., 1998), this vesicle–motor system switches to 
the actin filaments in the AMR, leading to a more even distribu-
tion of the vesicles and/or their cargoes such as Chs2 along the 
division site so that membrane deposition and/or PS formation 
can occur at a sharply defined position and correct timing, lead-
ing to efficient furrowing during cytokinesis. Alternatively, the 
actin ring may affect PS formation indirectly via its potential 
role in regulating Myo1 dynamics during cytokinesis. The relay 
mechanism may also operate during animal cytokinesis, except 
in this case it involves the switching of vesicle/cargo from a   
microtubule-based long-range transport system to an actin-based 
short-range transport system. A similar mechanism has been 
hypothesized  for  cargo  transport  in  nondividing  mammalian 
cells (Ross et al., 2008). Myo1 is also capable of guiding PS 
formation independently of the actin ring (Fig. 6), suggesting that 
Myo1 may interact directly with some of the components in-
volved in PS formation (Nishihama et al., 2009). Together, our 
data indicate that the AMR functions as a structural unit to guide 
membrane deposition and PS formation during cytokinesis.
In cells carrying Myo1 tail only, the motor domain– 
dependent force is eliminated while the force generated by mem-
brane deposition and ECM remodeling remains effective, as Myo1 
tail is still capable of directing the assembly of a headless AMR that 
can largely guide PS formation (Fig. 5), which explains, at least in 
part, why cytokinesis can still occur without the motor domain.
Why is the motor activity of myosin II 
differentially required for cytokinesis in 
different organisms?
Why is the motor activity of myosin II not required for cyto-
kinesis in budding yeast but required in fission yeast (Lord et al., 
2005) and animal cells (Straight et al., 2003)? The answer may 
lie in the cell dimension at the division site. The diameter of   
the division site varies tremendously depending on organisms 
and cell types, from 1 µm in budding yeast (Bi et al., 1998;   
Lippincott and Li, 1998) to 3.5 µm in fission yeast (Mitchison, 
1957), to more than 15–20 µm in animal cells (Carvalho et al., 
2009). However, all these organisms or cell types must com-
plete cytokinesis within a similar period of time. Assuming that 
there is no AMR contraction, for budding yeast, it requires only 
50 post-Golgi vesicles (the average diameter is 100 nm) for 
membrane closure during cytokinesis, but would require 613 
vesicles for fission yeast and 20,000 vesicles for an animal 
cell of 20 µm diameter to achieve the same feat during the same 
period of time. Thus, even in the complete absence of the AMR 
such as in myo1 cells, cytokinesis can still occur in budding 
yeast (Bi et al., 1998; Schmidt et al., 2002), presumably due to 
inefficient and AMR-independent vesicle fusion (and septum 
formation) at the division site. However, for cells with a large 
division diameter, the motor activity of the myosin II is presumably 
required to power the invagination of the plasma membrane in 
order to reduce membrane requirement and achieve efficient 
cytokinesis within a given period of time. Thus, the basic forces 
and mechanisms governing cytokinesis are likely the same in 
yeast and animal cells, but the proportionality of each force in 
driving cytokinesis to completion may vary depending on the 
dimension of the division site for each organism or cell type.
Materials and methods
Yeast strains, growth media, and genetic methods
Yeast strains used in this study are listed in Table II. Standard culture media 
and genetic methods were used throughout this study (Guthrie and Fink, 
1991). Where noted, 1 mg/ml 5-fluoroorotic acid (5-FOA; Research Prod-
ucts International) was added to medium to select for the loss of URA3- 
containing plasmids.
Plasmids
Plasmids used in this study are listed in Table III. All primers were purchased 
from Integrated DNA Technologies through the Cell Center at the University 
assembly (Eng et al., 1998; Takaine et al., 2009). Thus, the   
second-phase targeting mechanism in both organisms acts   
during cytokinesis and appears to involve the conserved pro-
teins ELC and IQGAP. In Dictyostelium, the tail-mediated   
myosin II targeting to the division site depends on its higher- 
order assembly (Zang and Spudich, 1998; Shu et al., 2003). 
However, how the assembled myosin II filaments find the cell 
middle remains unknown. In mammalian cells (Beach and 
Egelhoff, 2009), the tail of a nonmuscle myosin II localizes   
to the cleavage furrow independently of its assembly domain 
Figure 7.  Biphasic targeting of Myo1 and the guiding role of the actomy-
osin ring in membrane deposition and ECM remodeling during cytokinesis. 
(A) A model for the biphasic targeting of Myo1 during the cell cycle. Myo1 
targeting before cytokinesis is mediated solely by the septin-binding pro-
tein Bni5. Myo1 targeting during cytokinesis depends on Mlc1 and Iqg1. 
Iqg1, Myo1, and actin filaments at the bud neck likely define the minimal 
components of the AMR. (B) A model for the guiding role of the AMR in 
PS formation. In addition to force generation, the AMR may function as a 
“compass” to guide membrane deposition and ECM remodeling (PS for-
mation in yeast) during cytokinesis by capturing and distributing vesicles 
and their cargoes along the division site. This motor-independent guidance 
role of the AMR is sufficient to ensure membrane closure during cytokinesis 
for small cells such as budding yeast, but not for the larger ones such as 
fission yeast and animal cells.1345 Myo1 tail-mediated targeting and furrow ingression • Fang et al.
of Pennsylvania (Philadelphia, PA). Sequencing of constructs was performed 
at the DNA Sequencing Facility, University of Pennsylvania.
Similar  to  the  construction  of  plasmid  pRS316-N-MYO1-GFP,   
which contains MYO1 under its own promoter control and carries a NotI   
GFP
F64L/S65T/V163A  cassette  inserted  immediately  after  the  start  codon  of 
MYO1 (Caviston et al., 2003), plasmid pRS316-MYO1-C-GFP was con-
structed by inserting the same NotI-GFP cassette right before the stop   
codon of MYO1. Both plasmids were used as templates in PCR-mediated 
mutagenesis to generate plasmids containing different myo1 deletion al-
leles presented in Fig. 1 C.
Plasmid pRS316-MYO1-mCherry and YIp211-CDC3-mCherry were 
constructed by replacing the NotI-GFP cassette in pRS316-MYO1-C-GFP and 
YIp211-CDC3-GFP (Caviston et al., 2003), respectively, with the NotI-mCherry 
cassette in the plasmid YIp128-CDC3-mCherry (Gao et al., 2007).
Plasmid  pUG23-MYO1  was  constructed  by  PCR-amplifying  the 
MYO1 ORF from YCp50-MYO1 (Vallen et al., 2000) and gap-repairing 
into  EcoRI-digested  pUG23  (provided  by  J.  Hedgemann,  Heinrich- 
Heine-Universität, Düsseldorf, Germany), generating N-terminally tagged   
GFP-MYO1 that is under MET25 promoter control. GFP-Myo1 expressed 
from this plasmid was able to fully complement the cytokinesis defects   
of the myo1 cells even when the cells were grown in standard synthetic 
media,  which  contains  some  methionine  that  normally  represses  the   
MET25 promoter.
Plasmid  pFA6a-mCherry-KanMX6  was  constructed  by  replacing   
the  PacI–AscI  fragment  carrying  GFP  in  plasmid  pFA6a-GFP-KanMX6 
(Longtine et al., 1998) with the PacI–AscI fragment carrying mCherry from 
pKT355 (or pFA6a-link-mCherry-His3MX6), provided by K. Thorn (University 
of California, San Francisco, San Francisco, CA).
Plasmids carrying C-terminally TAP-tagged myo1 alleles were made 
in several steps. First, a C-terminal TAP tag (CBP-TEV-ProtA) was PCR-amplified 
from plasmid pBS1479 (Puig et al., 2001), generating a 588-bp TAP frag-
ment flanked by symmetrical restriction sites that were introduced in the 
PCR primers, HindIII–NotI–TAP–NotI–HindIII. This fragment was then di-
gested by HindIII and subscloned into pUC18 (Life Technologies Co.) at the 
HindIII site, yielding the plasmid pUC18-C-TAP. The correctness of the plas-
mid was confirmed by restriction-enzyme digestion and sequencing. Plasmids 
pRS316-MYO1-C-TAP and pRS316-MYO1-TD2-C-TAP were constructed by 
replacing the NotI-GFP cassette in plasmids pRS316-MYO1-C-GFP and 
pRS316-MYO1-TD2-C-GFP (see above) with the NotI-TAP cassette iso-
lated from plasmid pUC18-C-TAP.
Plasmids pMAL-MYO1-TD1, pMAL-MYO1-mTD1, and pMAL-MYO1-
TD2, which express MBP-tagged Myo1 fragments, were constructed by 
PCR amplifying myo1 fragments (myo1-TD1, myo1-mTD1, and myo1-
TD2)  from  the  derivatives  of  pRS316-MYO1-C-GFP  described  above 
and subcloning as SalI–PstI fragments (SalI and PstI sites were intro-
duced in the forward and reverse primers, respectively) into SalI- and 
PstI-digested pMAL-c2 (New England Biolabs, Inc.). Plasmid pGEX-5X-
BNI5, which expresses GST-tagged Bni5, was constructed by first PCR 
amplifying and gap repairing BNI5 ORF into the EcoRI site of plasmid 
pJG-4-5 (Gyuris et al., 1993), and then subcloning a BamHI–XhoI frag-
ment carrying BNI5 ORF from pJG4-5-BNI5 into the corresponding sites 
of pGEX-5X-1 (GE Healthcare).
Plasmid pRS315-IQG1 was constructed by cloning a 7-kb SacI–SalI 
IQG1 fragment from p1868 into SacI–SalI-digested pRS315 (Korinek et al., 
2000).  Plasmid  pRS315-IQG1-GST,  which  expresses  C-terminally  GST-
tagged  Iqg1,  was  constructed  by  PCR  amplifying  GST-His3MX6  from 
pFA6a-GST-His3MX6 (Longtine et al., 1998) and transforming the PCR 
product into yeast cells carrying pRS315-IQG1. Candidate plasmids were 
rescued from yeast cells and transformed into Escherichia coli for confirma-
tion by colony PCR and then further confirmed by sequencing. Plasmid 
pRS315-IQG1(1–697)-GST was constructed in a similar way except that 
the PCR-amplified GST-His3MX6 was inserted in-frame after amino acid 
697 of Iqg1, resulting in the deletion of residues 698–1495 from Iqg1. 
Plasmid  pRS315-IQG1(2-411)-GST  was  constructed  by  a  PCR-based 
method using appropriate mutagenic primers that resulted in the removal 
of residues 2–411 from Iqg1.
Precise replacement of the endogenous MYO1 with different myo1 alleles
We developed a genetic system in which the endogenous MYO1 can be 
precisely replaced by any myo1 allele containing truncation(s) or point 
mutation(s)  without  leaving  any  undesired  nucleotides  at  the  MYO1  
locus. Recipient strain Masa1243 [a myo1::URA3-KanMX6 (pUG23-
MYO1)] was constructed by first using a URA3 PCR fragment containing 
300-bp  upstream  sequences  and  150-bp  downstream  sequences  of 
URA3 to replace MYO1 ORF in the wild-type strain YEF473A carrying 
plasmid pUG23-MYO1, and then inserting KanMX6, which was PCR 
short-range transport system. A similar mechanism has been 
hypothesized  for  cargo  transport  in  nondividing  mammalian 
cells (Ross et al., 2008). Myo1 is also capable of guiding PS 
formation independently of the actin ring (Fig. 6), suggesting that 
Myo1 may interact directly with some of the components in-
volved in PS formation (Nishihama et al., 2009). Together, our 
data indicate that the AMR functions as a structural unit to guide 
membrane deposition and PS formation during cytokinesis.
In cells carrying Myo1 tail only, the motor domain– 
dependent force is eliminated while the force generated by mem-
brane deposition and ECM remodeling remains effective, as Myo1 
tail is still capable of directing the assembly of a headless AMR that 
can largely guide PS formation (Fig. 5), which explains, at least in 
part, why cytokinesis can still occur without the motor domain.
Why is the motor activity of myosin II 
differentially required for cytokinesis in 
different organisms?
Why is the motor activity of myosin II not required for cyto-
kinesis in budding yeast but required in fission yeast (Lord et al., 
2005) and animal cells (Straight et al., 2003)? The answer may 
lie in the cell dimension at the division site. The diameter of   
the division site varies tremendously depending on organisms 
and cell types, from 1 µm in budding yeast (Bi et al., 1998;   
Lippincott and Li, 1998) to 3.5 µm in fission yeast (Mitchison, 
1957), to more than 15–20 µm in animal cells (Carvalho et al., 
2009). However, all these organisms or cell types must com-
plete cytokinesis within a similar period of time. Assuming that 
there is no AMR contraction, for budding yeast, it requires only 
50 post-Golgi vesicles (the average diameter is 100 nm) for 
membrane closure during cytokinesis, but would require 613 
vesicles for fission yeast and 20,000 vesicles for an animal 
cell of 20 µm diameter to achieve the same feat during the same 
period of time. Thus, even in the complete absence of the AMR 
such as in myo1 cells, cytokinesis can still occur in budding 
yeast (Bi et al., 1998; Schmidt et al., 2002), presumably due to 
inefficient and AMR-independent vesicle fusion (and septum 
formation) at the division site. However, for cells with a large 
division diameter, the motor activity of the myosin II is presumably 
required to power the invagination of the plasma membrane in 
order to reduce membrane requirement and achieve efficient 
cytokinesis within a given period of time. Thus, the basic forces 
and mechanisms governing cytokinesis are likely the same in 
yeast and animal cells, but the proportionality of each force in 
driving cytokinesis to completion may vary depending on the 
dimension of the division site for each organism or cell type.
Materials and methods
Yeast strains, growth media, and genetic methods
Yeast strains used in this study are listed in Table II. Standard culture media 
and genetic methods were used throughout this study (Guthrie and Fink, 
1991). Where noted, 1 mg/ml 5-fluoroorotic acid (5-FOA; Research Prod-
ucts International) was added to medium to select for the loss of URA3- 
containing plasmids.
Plasmids
Plasmids used in this study are listed in Table III. All primers were purchased 
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Table II. S. cerevisiae strains used in this study
Strain Genotype Reference or source
YEF473A a his3 leu2 lys2 trp1 ura3 (Bi and Pringle, 1996)
YEF1820 a/ his3/his3 leu2/leu2 lys2/lys2 trp1/trp1 ura3/ura3 myo1::KanMX6/myo1::HIS3 (Bi et al., 1998)
YEF1804 As YEF473A except myo1::KanMX6 (Bi et al., 1998)
YEF5762 As YEF473A except CHS2-GFP:His3MX6 This study
a
YEF5804 As YEF473A except CDC3-mCherry:LEU2 This study
b
YEF5874 As YEF473A except CHS2-GFP:His3MX6 CDC3-mCherry:LEU2 This study
c
YEF5986 As YEF473A except MYO2-GFP:His3 CDC3-mCherry:LEU2 This study
c
YEF6179 a mlc1-11 MYO1-GFP:KanMX6 CDC3-mCherry:LEU2 This study
d
YEF6113 a MYO1-GFP:His3MX6 NUP57-GFP:URA3 his3 leu2 lys2 ura3 This study
e
YEF6307 a MYO1-GFP NUP57-GFP:URA3 This study
f
YEF6308 a myo1-TD2-GFP NUP57-GFP:URA3 This study
f
YEF6309 a myo1-Tail-GFP NUP57-GFP:URA3 This study
f
YEF6310 a myo1-TD2-GFP NUP57-GFP:URA3 This study
f
YEF6316 a bni5::His3MX6 MYO1-GFP NUP57-GFP:URA3 This study
f
YEF6321 a MYO1-GFP BNI5-mCherry:KanMX6 This study
g
YEF6322 a bni5::His3MX6 myo1-TD2-GFP This study
h
YEF6323 a bni5::His3MX6 myo1-TD2-GFP CDC3-mCherry:LEU2 This study
h
YEF6325 a iqg1::His3MX6 CDC3-mCherry:LEU2 [pRS316-MYO1-C-GFP] This study
i
YEF6326 a myo1-mTD1-GFP BNI5-mCherry:KanMX6 This study
j
Y5005-8D As YEF473A except mlc1-11 (Luo et al., 2004)
YKT520 As YEF473A except MYO2-GFP:HIS3 K. Tanaka
YKT662 As YEF473A except MYO2-GFP:TRP1 K. Tanaka
RNY970 As YEF473A except iqg1::His3MX6 [YCp50-IQG1] J.R. Pringle
RNY2594 As YEF473A except iqg1::His3MX6 MYO1-GFP:KanMX6 [pRS315-IQG1-GST] This study
k
RNY2595 As YEF473A except iqg1::His3MX6 MYO1-GFP:KanMX6 [pRS315-IQG1(2-411)-GST] This study
k
RNY2596 As YEF473A except iqg1::His3MX6 MYO1-GFP:KanMX6 CDC3-mCherry:URA3  
[pRS315-IQG1-GST]
This study
l
RNY2597 As YEF473A except iqg1::His3MX6 MYO1-GFP:KanMX6 CDC3-mCherry:URA3  
[pRS315-IQG1(2-411)-GST]
This study
l
Masa1243 As YEF473A except myo1::URA3-KanMX6 [pUG23-MYO1] See text
YJL221A As YEF473A except myo1-TD1-GFP See text
YJL222A As YEF473A except myo1-TD2-GFP See text
YJL335A As YEF473A except myo1-Tail-GFP See text
YJL376A As YEF473A except myo1-AD-GFP See text
YJL488A As YEF473A except myo1-TD2-GFP See text
YJL489A As YEF473A except myo1-mTD1-GFP See text
XDY7 YEF1820 [pRS316-MYO1-C-TAP] This study
XDY41 As YEF473A except MYO1-GFP See text
XDY99 YEF1820 [pRS316-MYO1-TD2-C-TAP] This study
XDY154 YEF473A [pRS316-MYO1-TD2-GFP] This study
m
XDY173 a mlc1-11 [pRS316-MYO1-TD2-GFP] This study
m
XDY189 a myo1-mTD1-GFP BNI5-3HA:His3MX6 This study
n
XDY190 a myo1-Tail-GFP BNI5-3HA:His3MX6 This study
n
XDY191 a myo1-TD1-GFP BNI5-3HA:His3MX6 This study
n
XDY192 a myo1-TD2-GFP BNI5-3HA:His3MX6 This study
n
XDY194 a myo1-AD-GFP BNI5-3HA:His3MX6 This study
n
XDY211 a myo1-mTD1-GFP BNI5-mCherry:KanMX6 [pRS316-N-NotI-MYO1] This study
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amplified from pFA6a-KanMX6 (Longtine et al., 1998), after the URA3 at 
the myo1 locus.
Plasmids  pRS316-N-MYO1-GFP  and  pRS316-MYO1-C-GFP  and 
their derivatives carrying different myo1 alleles were digested with SalI 
and ClaI, and then transformed into Masa1243. The transformation mix-
tures were plated out on SC-His plates and incubated at 25°C for 2 d. After 
cells were grown to confluency on SC-His plates, the cells were replicated 
onto SC-His+ 5-FOA plates to select for Ura
 cells, and then screened for 
G418 sensitivity on YPD+G418 plates to get Ura
 Kan
s cells in which the 
URA3-KanMX6 cassette at the myo1 locus was replaced by the incoming 
myo1 allele. The resulting colonies were then grown in non-selective YPD 
medium to lose the plasmid pUG23-MYO1.
Table II. S. cerevisiae strains used in this study (Continued)
Strain Genotype Reference or source
XDY218 a iqg1::His3MX6 [pRS316-MYO1-TD2-GFP] This study
p
XDY254 a MYO1-GFP bni5::His3MX6 This study
n
XDY257 a myo1-TD2-GFP bni5::His3MX6 This study
n
XDY258 a myo1-mTD1-GFP bni5::His3MX6 This study
n
XDY286 a MYO1-GFP CDC3-mCherry:LEU2 This study
q
XDY287 a bni5::His3MX6 MYO1-GFP CDC3-mCherry:LEU2 This study
q
XDY288 a myo1-Tail-GFP CDC3-mCherry:LEU2 This study
q
XDY289 a myo1-TD2-GFP CDC3-mCherry:LEU2 This study
q
XDY290 a myo1-TD2-GFP CDC3-mCherry:LEU2 This study
q
XDY295 a iqg1::His3MX6 [pRS316-MYO1-TD2-GFP] [pRS315-IQG1-GST] This study
p
XDY296 a iqg1::His3MX6 [pRS316-MYO1-TD2-GFP] [pRS315-IQG1(1-697)-GST] This study
p
XDY300 a iqg1::His3MX6 [pRS316-MYO1-TD2-GFP] [pRS315-IQG1(2-411)-GST] This study
p
aConstructed by a PCR-based method (Longtine et al., 1998).
bConstructed by transforming BglII-digested YIp128-CDC3-mCherry (Gao et al., 2007) into YEF473A and integrating at the CDC3 locus.
cConstructed by PCR-amplifying CHS2-GFP:HIS3MX6 and MYO2-GFP:HIS3 fragments from YEF5762 and YKT520, respectively, and transforming  
into YEF5804.
dConstructed by transforming Y5005-8D with a MYO1-GFP:KanMX6 fragment that was PCR-amplified from YEF2293 (Luo et al., 2004), followed by 
integration of BglII-digested YIp128-CDC3-mCherry at the CDC3 locus.
eConstructed by a PCR-based method(Longtine et al., 1998) using plasmids pFA6a-GFP-His3MX6 (Longtine et al., 1998) and pFA6a-GFP-URA3 (pro-
vided by C. Burd, University of Pennsylvania, Philadelphia, PA) as templates for tagging MYO1 and NUP57, respectively. The PCR fragments containing 
MYO1-GFP:His3MX6 and NUP57-GFP:URA3 were transformed sequentially into strain RLY1 (Winter et al., 1999).
fConstructed by transforming PCR-amplified NUP57-GFP:URA3 from YEF6113 into strains XDY41, YJL488A, YJL335A, YJL222A, and XDY254, respectively.
gConstructed by transforming PCR-amplified BNI5-mCherry:KanMX6 from XDY211 into XDY41.
hConstructed by transforming PCR-amplified bni5::His3MX6 from XDY254 into YJL448A and XDY289, respectively.
iStrain XDY218 was first transformed by BglII-digested YIp128-CDC3-mCherry and then streaked on a SC-Leu + 5-FOA plate to select for the loss of plas-
mid pRS316-MYO1-TD2-GFP. The resulting strain was then transformed with plasmid pRS316-MYO1-C-GFP.
jConstructed by streaking XDY211 on a SC + 5-FOA plate to select for the loss of plasmid pRS316-N-NotI-MYO1.
kStrain RNY1264 (iqg1::His3MX6 MYO1-GFP:KanMX6 [YCp50-IQG1]) was transformed with pRS315-IQG1-GST or pRS315-IQG1(2-411)-GST, and 
the resulting strains were streaked on a SC-Leu + 5-FOA plate to eliminate YCp50-IQG1.
lConstructed by transforming BglII-digested YIp211-CDC3-mCherry into strains RNY2594 and RNY2595 and integrating at the CDC3 locus.
mConstructed by transforming the plasmid into YEF473A and Y5005-8D, respectively.
nStrains carrying different myo1 alleles were transformed with plasmid pRS316-MYO1. The resulting strains were either 3HA-tagged or deleted  
for BNI5 using a PCR-based method (Longtine et al., 1998), and then selected for the loss of the MYO1 plasmid by growing cells in non-selective 
YPD medium.
oConstructed by transforming a BNI5-mCherry:KanMX6 fragment that was PCR-amplified from plasmid pFA6a-mCherry-KanMX6 into YJL489A carrying 
plasmid pRS316-N-NotI-MYO1 (Caviston et al., 2003).
pStrain RNY970 (shown in the table) was streaked from a SC-His plate onto a SC-His + 5-FOA plate; the resulting single colonies were checked by PCR 
to confirm the loss of the IQG1 plasmid. The resulting iqg1::His3MX6 strain was then transformed with indicated plasmids to generate strains XDY218, 
XDY295, XDY296, and XDY300.
qStrains XDY41, XDY287, YJL335A, YJY222A, and YJY488A were transformed with plasmid pRS316-MYO1. The resulting strains were then trans-
formed with BglII-digested integrative plasmid YIp128-CDC3-mCherry and transformants were selected on SC-Leu plates at 25°C and then grown in 
non-selective YPD medium to lose the MYO1 plasmid.
Purification of TAP-tagged Myo1 from yeast cells
Myo1-C-TAP and Myo1-TD2-C-TAP were purified as described previously 
(Puig et al., 2001), with some modifications. Eight liters of myo1 cells 
carrying pRS316-MYO1-C-TAP or pRS316-MYO1-TD2-C-TAP were grown 
in SC-Ura medium at 23°C to an OD600 = 2.0–3.0, collected by centrifuga-
tion, washed twice with water, resuspended into 40.0 ml cell lysis buffer 
(CLB; 50 mM Hepes-KOH, pH 7.9, 150 mM NaCl, 5 mM MgCl2, 5 mM 
ATP, 0.1% NP-40, and 2 mM Benzamidine), and added 1.0 ml 100x pro-
tease inhibitor cocktail (with stock concentrations of 50 µg/ml leupeptin, 
140 µg/ml pepstatin A, 240 µg/ml chymostatin, 1.7 mg/ml aprotinin, 
0.25 mg/ml antipain, and 35 µg/ml bestatin) and 0.5 ml 100× phospha-
tase inhibitor cocktail I (Sigma-Aldrich). The cell suspension was passed JCB • VOLUME 191 • NUMBER 7 • 2010   1348
1 µl rabbit polyclonal GFP antibody (Abcam) and 30 µl protein A agarose 
beads (Life Technologies Co.). After incubation at 4°C for 12–16 h, beads 
were washed five times each with 200 µl lysis buffer without protease and 
phosphatase inhibitors, and proteins bound to the beads were boiled with 
100 µl SDS-sample buffer. The precipitated Myo1-GFP variants, the total 
Bni5-HA in cell lysates, and the bound fractions of Bni5-HA were analyzed 
by SDS-PAGE and blotted with anti-GFP, and anti-HA monoclonal antibodies, 
respectively (Covance).
Production of recombinant proteins and in vitro binding assay
E. coli strain BL21(DE3) containing appropriate constructs for expressing 
recombinant proteins was grown in 30–600 ml LB plus 100 mg/ml ampi-
cillin at 37°C to OD600 ≤ 1.0. Expression of recombinant proteins was   
induced with 1 mM IPTG at 23°C for 3 h. Cells were then collected by   
centrifugation, washed twice with water, resuspended into 5–20 ml cell   
lysis buffer (CLB [the CLB for MBP-tagged proteins: 20 mM Tris-HCl, pH 8.0, 
100 mM NaCl, 5 mM EDTA, 5 mM DTT, 0.1% NP-40, and 2× complete 
protein inhibitor cocktail tablets; Roche Diagnostics Co.; the CLB for GST-
tagged protein: 1x PBS, 5 mM EDTA, 5 mM DTT, 0.1% NP-40, and 2× 
complete protein inhibitor cocktail]). Cells were then broken by sonicating 
for 7 x 15 s with 15-s interval on ice, centrifuged at 15,000 rpm for 20 min 
at 4°C. Supernatant was collected and incubated with prewashed amylose 
beads (New England Biolabs, Inc.) for MBP-tagged proteins or glutathione 
Sepharose 4B beads (GE Healthcare) for GST-tagged proteins at 4°C for   
1 h. Beads were then washed three times each with 5.0 ml corresponding 
CLB buffer. MBP-tagged proteins were resuspended in 1.0 ml CLB. GST-
tagged proteins were eluted five times each with 200 µl elution buffer, 
which is the CLB for MBP-tagged proteins, except containing 10 mM   
reduced glutathione and lacking the protease inhibitors.
The concentrations of the purified recombinant proteins were esti-
mated by comparing the sample proteins to bovine serum albumin (BSA) of 
known concentrations by SDS-PAGE analysis, followed by staining the gel 
with simple blue (Life Technologies Co.). Approximately 40 µg MBP-tagged 
proteins that were still bound on beads were added to different 1.5-ml   
Eppendorf tubes, the amount of beads was normalized by adding more 
prewashed beads, and then incubated with 500 µl 5% BSA at 4°C for 1 h 
to block nonspecific binding by the beads. After a brief centrifugation to 
pellet the beads and remove the supernatant, the beads were mixed with   
10 µg GST-tagged protein. The CLB for MBP-tagged proteins without the 
protease inhibitors was added to the reaction to make the final volume of 
500 µl. The binding reaction was incubated with rotation at 4°C for 1 h, and 
through a French press three times with a pressure ≤ 1,200 psi to break 
down the cells, which was followed by centrifugation at 100,000 g for 
150 min at 4°C to clear the cell lysate. The supernatant was then mixed 
with 500 µl IgG beads (GE Healthcare), which had been prewashed five 
times with 5.0 ml CLB. The mixture was incubated with rotation at 4°C 
overnight. The beads were spun down, washed five times each with 10.0 ml 
CLB, once with 10.0 ml TEV cleavage buffer (10 mM Hepes-KOH, pH 7.9, 
150 mM NaCl, 0.5 mM EDTA, 1 mM DTT, and 0.1% NP-40), resuspended   
in 1.0 ml TEV cleavage buffer plus 150 U AcTEV Protease (Life Technol-
ogies Co.), and then incubated with rotation at 4°C overnight. Approxi-
mately 1.0 ml of supernatant containing Myo1 was separated from IgG 
beads by passing through a column. The column was then washed five 
times each with 2.0 ml calmodulin binding buffer (CBB; 10 mM Hepes-
KOH, pH 7.9, 150 mM NaCl, 1 mM Mg acetate, 1 mM imidazole, 2 mM 
CaCl2, 10 mM 2-mercaptoethnol, and 0.1% NP-40). The supernatant and 
the flow-through from the washes were combined, totaling 11.0 ml in 
volume, to which 10 µl 1.0 M CaCl2 was added. This protein solution was 
mixed with 100 µl Calmodulin Affinity Resin (Agilent Technologies), which 
had been prewashed three times each with 5.0 ml CBB. The mixture was 
incubated with rotation at 4°C for 2 h, and then passed through a column, 
which was followed by three washes each with 10.0 ml CBB. The protein 
was then eluted 10 times each with 200 µl calmodulin elution buffer (10 mM 
Hepes-KOH, pH 7.9, 150 mM NaCl, 1 mM Mg acetate, 1 mM imidazole, 
20 mM EGTA, 10 mM 2-mercaptoethnol, and 0.1% NP-40).
The  combined  eluents  from  the  experiments  above  were  passed 
through Amicon ultra centrifugal filter devices with suitable MWCO (Milli-
pore) to change the buffer into 2x EM buffer (300 mM KCl, 2 mM MgCl2, 
2 mM EGTA, 2 mM DTT, 20 mM imidazole-HCl, pH 7.0, and 400 µM 
ADP), which was then diluted by equal volume of 100% glycerol to make 
Myo1 preparation in 1x EM buffer for EM observation (see below). The   
final concentrations of Myo1-C-TAP and myo1-TD2-C-TAP in the EM buffer 
were 10 µg/ml.
Coimmunoprecipitation experiments
100 OD600 of yeast cells grown exponentially in SC-His media were dis-
rupted by vortexing with glass beads at 4°C in 500 µl of 1x PBS buffer 
(137 mM NaCl, 2.7 mM KCl, 10 mM sodium phosphate dibasic, and   
2 mM potassium phosphate monobasic, pH 7.4) containing 0.1% NP-40 
and a cocktail of protease inhibitors (5x stock) and phosphatase inhibitors 
(5x cocktail-I stock) for yeast (Sigma-Aldrich). After centrifugation to re-
move cell debris, the supernatant was used for immunoprecipitation with   
Table III. Plasmids used in this study
Plasmid Description Reference or source
pUG23-MYO1 CEN, HIS3, pMET25-yEGFP3, MYO1 See text
pRS316-N-MYO1-GFP CEN, URA3, GFP-MYO1 (Caviston et al., 2003)
pRS316-MYO1-C-GFP CEN, URA3, MYO1-GFP See text
pRS316-MYO1-TD2 -GFP CEN, URA3, myo1-TD2-GFP See text
pRS316-MYO1-TD2-GFP CEN, URA3, myo1-TD2-GFP See text
pRS316-MYO1-TD1-GFP CEN, URA3, myo1-TD1-GFP See text
pRS316-MYO1-mTD1-GFP CEN, URA3, myo1-mTD1-GFP See text
pUC18-C-TAP C-TAP See text
pRS316-MYO1-C-TAP CEN, URA3, MYO1-C-TAP See text
pRS316-MYO1-TD2-C-TAP CEN, URA3, MYO1-TD2-C-TAP See text
pRS316-MYO1-mCherry CEN, URA3, MYO1-mCherry See text
pMAL-c2 malE (or N-MBP) New England Biolabs
pMAL-MYO1-TD1 MBP-myo1-TD1 See text
pMAL-MYO1-mTD1 MBP-myo1-mTD1 See text
pMAL-MYO1-TD2 MBP-myo1-TD2 See text
pGEX-5X-BNI5 GST-BNI5 See text
YIplac128-CDC3-mCherry Integrative, LEU2, mCherry (RFP)-CDC3 (Gao et al., 2007)
YIplac211-CDC3-mCherry Integrative, URA3, mCherry (RFP)-CDC3 See text
pRS315-IQG1 CEN, LEU2, IQG1 See text
pRS315-IQG1-GST CEN, LEU2, IQG1-GST See text
pRS315-IQG1-(1-697)-GST CEN, LEU2, iqg1(1-697)-GST See text
pRS315-IQG1(2-411)-GST CEN, LEU2, iqg1(1, 412-1495)-GST See text
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myo1-TD2-GFP localization to the bud neck in bni5 cells. Video 6 shows 
the localization of Myo1 in bni5 cells versus localization of myo1-TD2 
during the cell cycle. Video 7 shows three-dimensional construction of the 
actin ring in a myo1-Tail cell. Video 8 shows the localization of Myo1   
versus Myo2 and Chs2 during the cell cycle. Video 9 shows the localiza-
tion of Myo2 and Chs2 versus Cdc3 during the cell cycle. Video 10 shows 
the constriction patterns of Myo1 ring in the presence of full-length IQG1 
versus iqg1(2-411). Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201005134/DC1.
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then spun down to pellet the beads, which were then washed three times 
each with 500 µl binding buffer at 4°C for 10 min. The final protein com-
plexes were eluted by adding 100 µl 2x SDS sample buffer and boiled for 
5 min, resolved by SDS-PAGE and analyzed by Western blotting.
For EM observation, MBP-myo1-Tail-TD2 was purified essentially 
as described above except that 600 ml culture was used and the recombi-
nant protein was eluted from the amylose beads using maltose. The buffer 
for the protein suspension was changed into 1x EM buffer as described for 
TAP-tagged Myo1 above. The final concentration of MBP-myo1-Tail-TD2 
was 100 mg/ml.
Light and EM
All cells were in exponential phase for imaging experiments. Differential 
interference contrast (DIC) and fluorescence microscopy were performed 
using a microscope (model E800; Nikon) equipped with a Plan Apochro-
mat  60x/1.40  NA  oil  immersion  objective  (Nikon),  a  CCD  camera 
(model C4742-95; Hamamatsu Photonics), and Image-Pro Plus software 
(Media Cybernetics).
For time-lapse microscopy, cells were spotted onto a thin layer of   
SC medium + 2% agarose on a microscope slide. Individual cells were   
followed at 1-min interval using IPLab software (BD) and a spinning-disk 
confocal microscope system comprising a scanner (CSU 10; Yokogawa), a 
microscope (IX 71; Olympus), a Plan S-Apo 100x/1.4 NA oil immersion 
objective  (Olympus),  and  an  ImagEM  back-thinned  EM  CCD  camera 
(C9100-13; Hamamatsu Photonics); components were integrated by Bio-
Vision Technologies. Diode lasers for excitation (488 nm for GFP; 561 nm 
for RFP) were housed in a launch constructed by Spectral Applied Re-
search. For each time point, 10 z-sections were acquired at 0.2- or 0.3-mm 
increments at 23°C. Maximum projection of images for each time point 
was generated using IPLab software. The contrast and the brightness of the 
images were enhanced using NIH ImageJ, and the finalized time-lapse 
data were presented as montages using ImageJ or as movies using Meta-
Morph (MDS Analytical Technologies). The constriction rate of Myo1 ring 
was determined as the diameter of Myo1 ring before constriction minus the 
diameter of the first Myo1 dot near the end of constriction divided by the 
time required to undergo this change. Only cells with symmetric Myo1 
constriction were used in the calculation.
For observation of Myo1-C-TAP, Myo1-TD2D-C-TAP, and MBP-myo1-
Tail-TD2D structures by rotary-shadowing EM, 5–10.0 µl of each protein 
suspensions in 1x EM buffer was sprayed on freshly split mica (Tyler and 
Branton, 1980; Rock et al., 2005). The droplets were dried under vacuum, 
rotary-shadowed with platinum at an angle of 7°, and replicated with car-
bon in a freeze-fracture apparatus (model BFA 400; Balzers Spa). The rep-
licas were photographed in an electron microscope (model 410; Philips) 
operating at 60 kV. The negatives were digitally scanned at 1,000 ppi, 
and the tail length of Myo1 and its derivatives was determined by measur-
ing individual molecules from the head–tail junction to the C-terminal end 
using Photoshop software.
For observation of PS in different myo1 and iqg1 mutants by trans-
mission  EM,  cells  were  fixed  and  processed  as  described  previously   
(Nishihama et al., 2009).
Latrunculin A treatment and actin staining
Cells were grown in YPD medium to exponential phase (OD600 = 0.5–1.0) 
and then treated with 1/100 volume of 20 mM latrunculin A (LatA) (Wako 
Chemicals USA, Inc.) or DMSO (solvent in which LatA was dissolved) for 
30 min, then added 1/10 volume of 37% formaldehyde for fixation at 
24°C for 30 min. Cells were then washed with PBS, permeabilized with 
PBS plus 0.2% Triton X-100, and stained for F-actin and DNA as described 
previously (Bi et al., 1998).
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Fig. S1 shows coiled-coil profiles of myosin IIs from different organisms or 
cell types. Fig. S2 shows myo1-TD2-GFP in bni5 and LatA-treated cells. 
Fig. S3 shows disassembly defect of Myo1 tail during and after cytokinesis, 
and quantitative analysis of constriction behaviors of the full-length Myo1   
in wild-type and bni5 cells as well as in cells carrying different myo1 
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tant cells, and the timing of Myo2 and Chs2 localization with respect to 
septin-hourglass splitting during the cell cycle. Video 1 shows localization 
of Bni5 versus Myo1 and myo1-mTD1 during the cell cycle. Video 2 shows 
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cytokinesis in mlc1-11 and iqg1 cells. Video 3 shows the constriction   
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